UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Natural history of multiple system atrophy in the USA: a prospective cohort study

Lancet neurology, 2015-07, Vol.14 (7), p.710-719

2015

Volltextzugriff (PDF)

Classification and Natural History of the Neuronal Ceroid Lipofuscinoses

Journal of child neurology, 2013-09, Vol.28 (9), p.1101-1105

2013

Volltextzugriff (PDF)

The CLN3 Disease Staging System: A new tool for clinical research in Batten disease

Neurology, 2020-06, Vol.94 (23)

2020

Volltextzugriff (PDF)

Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial

Parkinsonism & related disorders, 2017-07, Vol.40 (C), p.18-26

2017

Volltextzugriff (PDF)

Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms

Parkinsonism & related disorders, 2019-03, Vol.60, p.126-132

2019

Volltextzugriff (PDF)

Multivariate Analyses of Peripheral Blood Leukocyte Transcripts Distinguish Alzheimer’s, Parkinson’s, Control and Those at Risk for Developing Alzheimer’s

Neurobiology of aging, 2017-10, Vol.58, p.225-237

2017

Volltextzugriff (PDF)

Potential outcome measures and trial design issues for multiple system atrophy

Movement disorders, 2007-12, Vol.22 (16), p.2371-2377

2007

Volltextzugriff (PDF)

Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis)

JIMD Reports, Volume 43, 2019, Vol.43, p.117-124

2019

Volltextzugriff (PDF)

Approach to the elderly patient with gait disturbance

Neurology. Clinical practice, 2012-06, Vol.2 (2), p.103-111

Marshall, Frederick J

2012

Volltextzugriff (PDF)

A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groups

Movement disorders, 2010-10, Vol.25 (13), p.2128-2135

2010

Volltextzugriff (PDF)

Experience, knowledge, and opinions about childhood genetic testing in Batten disease

Molecular genetics and metabolism, 2014-02, Vol.111 (2), p.197-202

2014

Volltextzugriff (PDF)

Methodology of clinical research in rare diseases: Development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates

Contemporary clinical trials, 2013-07, Vol.35 (2), p.48-54

2013

Volltextzugriff (PDF)

Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease)

Developmental medicine and child neurology, 2010-07, Vol.52 (7), p.637-643

2010

Volltextzugriff (PDF)

Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data

Journal of inherited metabolic disease, 2011-10, Vol.34 (5), p.1075-1081

2011

Volltextzugriff (PDF)

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial

Journal of clinical medicine, 2020-11, Vol.9 (11), p.3682

2020

Volltextzugriff (PDF)

Neuropsychological Symptoms of Juvenile-Onset Batten Disease: Experiences From 2 Studies

Journal of child neurology, 2007-05, Vol.22 (5), p.621-627

2007

Volltextzugriff (PDF)

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy

Movement disorders, 2007-03, Vol.22 (4), p.546-549

2007

Volltextzugriff (PDF)

Erratum to: Females experience a more severe disease course in batten disease

Journal of inherited metabolic disease, 2012-05, Vol.35 (3), p.559-559

2012

Volltextzugriff (PDF)

Cross-sectional and Longitudinal Natural History of CLN3 Disease Progression (583)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Age-at-onset and Time-to-event of Core Features in CLN3 (Batten) Disease (581)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Effect of an Intensive Mindful Practice Workshop on Patient-Centered Compassionate Care, Clinician Well-Being, Work Engagement, and Teamwork

The Journal of continuing education in the health professions, 2022-01, Vol.42 (1), p.19-27

2022

Volltextzugriff (PDF)

Culture and education policy in the American States

1989

Volltextzugriff (PDF)

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet neurology, 2023-06, Vol.22 (6), p.494-504

2023

Volltextzugriff (PDF)

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Lancet neurology, 2024-03, Vol.23 (3), p.243-255

2024

Volltextzugriff (PDF)

1 – 25 von 831

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(607)
Mit Volltextzugriff
(639)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Natural history of multiple system atrophy in the USA: a prospective cohort study

Classification and Natural History of the Neuronal Ceroid Lipofuscinoses

The CLN3 Disease Staging System: A new tool for clinical research in Batten disease

Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial

Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms

Multivariate Analyses of Peripheral Blood Leukocyte Transcripts Distinguish Alzheimer’s, Parkinson’s, Control and Those at Risk for Developing Alzheimer’s

Potential outcome measures and trial design issues for multiple system atrophy

Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis)

Approach to the elderly patient with gait disturbance

A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groups

Experience, knowledge, and opinions about childhood genetic testing in Batten disease

Methodology of clinical research in rare diseases: Development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates

Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease)

Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial

Neuropsychological Symptoms of Juvenile-Onset Batten Disease: Experiences From 2 Studies

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy

Erratum to: Females experience a more severe disease course in batten disease

Cross-sectional and Longitudinal Natural History of CLN3 Disease Progression (583)

Age-at-onset and Time-to-event of Core Features in CLN3 (Batten) Disease (581)

Effect of an Intensive Mindful Practice Workshop on Patient-Centered Compassionate Care, Clinician Well-Being, Work Engagement, and Teamwork

Culture and education policy in the American States

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Suchergebnisse filtern